Skip to content

Study to compare the effectiveness of Vrishadi Basti(medicated enema) with and without Kati Basti in treating prolapsed intervertebral disc-related sciatica.

Comparative study to evaulate the efficacy of vrishadi basti with and without kati basti in management of gridhrasi w.s.r Prolapse intervertebral disc. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/069967
Enrollment
40
Registered
2024-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M511- Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with radiculopathy

Interventions

None listed

Sponsors

Ayurvedic and unani tibbia college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patient have score between 25-50 as per OSWESTRY LOW BACK DISABILITY QUESTIONNAIRE. 2)Patient with MRI finding of PIVD stage (bulging disc, disc herniation, protrusion, extrusion). 3)Patients between the age group of 18-65 years

Exclusion criteria

Exclusion criteria: Patients who are contraindicated for Niruha Basti and Anuvasan basti such as - udar roga, intestinal perforation, intestinal obstruction Known case of spinal muscular atrophy, spina bifida, spinal tumors, osteoporosis and cauda equina syndrome Those patients who have PIVD along with Neurological disorder, muscles wasting and lack of muscle power Patients with renal or hepatic impairment (Sr creatinine greater than 1.8 mg/dl, SGOT and SGPT greater than Five times of upper limit) Patients with co-morbid conditions such as Hypertension (systolic greater than equal to 160 mm Hg and Diastolic greater than equal to 100 mm Hg despite antihypertensive medications) and Diabetes Mellitus (having HbA1c greater than 7.5% with or without oral hypoglycemic medication). Patients who are on antitubercular or antiretro viral medication. Patients requiring emergency treatment.

Design outcomes

Primary

MeasureTime frame
The proportion of patients showing improvement in subjective parameter (OSWESTRY LOW BACK DISABILITY QUESTIONNAIRE) and MRI post administration of Vrishadi aasthapan basti with and without kati bastiTimepoint: It wil be assessed by MRI finding and OSWESTRY LOW BACK DISABILITY QUESTIONNAIRE. on baseline post completion of treatment. After 30 days

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDrDeepak kumar

Ayurvedic and unani tibbia college and hospital

nitjin2005@gmail.com9811765501

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026